Balancing Personalization & Scalability in TCR-T Cell Therapies to Scale the Modality

• Examining drivers of efficiency in scalable personalized TCR-T asset development
• Synthesizing discovery with manufacturing to drive scalability of product development
• Designing clinical programs for near-term outcomes and pathways to approvals

Speakers:

Reagan Jarvis

Chief Executive Officer & Co-Founder

Anocca